Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cells
2010
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
2015 StandoutNobel
The Basic Principles of Chimeric Antigen Receptor Design
2013
Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions
2008
TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential
2021
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment
2019
MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers
2019
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Cancer immunotherapy: the beginning of the end of cancer?
2016
B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality
2015 StandoutNobel
Case Report of a Fatal Serious Adverse Event Upon Administration of T Cells Transduced With a MART-1-specific T-cell Receptor
2015
Breaking tolerance in cancer immunotherapy: time to ACT
2005
Is autoimmunity the Achilles' heel of cancer immunotherapy?
2017
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Therapeutic cancer vaccines: are we there yet?
2010
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
2015 Standout
Synovial Tissue Inflammation Mediated by Autoimmune T Cells
2019 StandoutNobel
Microbial tryptophan catabolites in health and disease
2018 Standout
Modular and tunable biological feedback control using a de novo protein switch
2019 StandoutNatureNobel
Hydrophobic mismatch drives self-organization of designer proteins into synthetic membranes
2024 StandoutNobel
Functional differences between low- and high-affinity CD8+T cells in the tumor environment
2012
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology
2013
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Genetic engineering of T cells for immunotherapy
2021
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
The Principles of Engineering Immune Cells to Treat Cancer
2017
Developing neoantigen-targeted T cell–based treatments for solid tumors
2019
Hepatocellular carcinoma
2021 Standout
CD137+CD154− Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from In Vitro Expansion Cultures
2018
Genetically engineered T cells for cancer immunotherapy
2019
Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic
2015
Adoptive immunotherapy for cancer: harnessing the T cell response
2012
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Delivery technologies for cancer immunotherapy
2019 Standout
Improving cancer immunotherapy through nanotechnology
2019
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
Next-generation regulatory T cell therapy
2019
Immunopathology of multiple sclerosis
2015 Standout
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Foxp3: a genetic foundation for regulatory T cell differentiation and function
2020 StandoutNobel
Treg Cells in Rheumatoid Arthritis: An Update
2013
Tertiary lymphoid structures in the era of cancer immunotherapy
2019
The PD‐1 pathway in tolerance and autoimmunity
2010 Standout
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
Targeting Treg signaling for the treatment of autoimmune diseases
2015
Paradoxical roles of the immune system during cancer development
2006 Standout
Th17 and regulatory T cell balance in autoimmune and inflammatory diseases
2014
Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity
2010
TREG-cell therapies for autoimmune rheumatic diseases
2014 StandoutNobel
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
2016 StandoutNobel
Disturbed Th17/Treg balance in patients with rheumatoid arthritis
2011
Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy
2011
Engineered T cells for cancer therapy
2014
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
The PI3K Pathway in Human Disease
2017 Standout
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
2010
Defining trained immunity and its role in health and disease
2020 Standout
Unbiased identification of target antigens of CD8+ T cells with combinatorial libraries coding for short peptides
2012
Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes
2016 StandoutNobel
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells
2015
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs)
2012
Treg cell-based therapies: challenges and perspectives
2019
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Adoptive Immunotherapy for Cancer or Viruses
2014
Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma
2020
Taking regulatory T cells into medicine
2021 StandoutNobel
Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation
2013
Regulatory T Cells and Human Disease
2020 StandoutNobel
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
B7x in the Periphery Abrogates Pancreas-Specific Damage Mediated by Self-reactive CD8 T Cells
2012 StandoutNobel
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Adoptive cellular therapy: A race to the finish line
2015
ICOS+Foxp3+TILs in gastric cancer are prognostic markers and effector regulatory T cells associated withHelicobacter pylori
2016 StandoutNobel
Relative paradigms between autoantibodies in lupus and autoantibodies in cancer
2003
Chimeric Antigen Receptor Therapy
2018 Standout
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Proenkephalin+regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function
2020 StandoutNobel
Regulatory T cells that recognize a ubiquitous stress-inducible self-antigen are long-lived suppressors of autoimmune arthritis
2012
Redirecting αβT cells against cancer cells by transfer of a broadly tumor-reactive γδT-cell receptor
2011
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Regulatory T cells expressing abundant CTLA‐4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer
2018 StandoutNobel
Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function
2021
Systemic Activation of NRF2 Alleviates Lethal Autoimmune Inflammation in Scurfy Mice
2017 StandoutNobel
Works of Gavin Bendle being referenced
Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis
2009
Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity
2015
TCR Gene Therapy of Spontaneous Prostate Carcinoma Requires In Vivo T Cell Activation
2008
Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy
2010
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers
2018
Preclinical development of T cell receptor gene therapy
2009
Adoptive T-Cell Therapy for Cancer in the United Kingdom: A Review of Activity for the British Society of Gene and Cell Therapy Annual Meeting 2015
2015
Prospects for immunotherapy of malignant disease
2003
Requirements for Effective Antitumor Responses of TCR Transduced T Cells
2008
Blockade of TGF-β Signaling Greatly Enhances the Efficacy of TCR Gene Therapy of Cancer
2013
Induction of Unresponsiveness Limits Tumor Protection by Adoptively Transferred MDM2-Specific Cytotoxic T Lymphocytes
2004
A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection
2005